Nasdaq · CIK 0001870144
CDIO Cardio Diagnostics Holdings, Inc.
B
80 / 100
Material weaknesses
1
Restatements
0
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
0
Deductions
20
Remediation credit
0
Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.
Disclosures, in the company's words
“Management identified the following material weakness in our internal control over financial reporting: inadequate segregation of duties within the financial reporting process due to our limited staff resources, which increases the risk of errors or unauthorized transactions.”
“Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this Report, our disclosure controls and procedures were not effective.”
Filings read
- 10-Q · 2026-11-06read
- 10-Q · 2026-08-07queued
- 10-Q · 2026-05-15queued
- 10-K · 2026-03-13queued
- 10-Q · 2025-11-12queued
- 10-Q · 2025-08-14queued
- 10-Q · 2025-05-15queued
- 10-K · 2025-03-20queued
- 10-Q · 2024-11-13queued
Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.